Capricor Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Capricor Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Capricor Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Capricor Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $7.3k | 252 | 28.86 |
| 2025-06-30 | $915k | 92k | 9.93 |
| 2025-03-31 | $562k | 59k | 9.49 |
| 2024-12-31 | $462k | 34k | 13.80 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas